Scientist in blue shirt thinking about research questions

What if I knew how well delivery of CRISPR/Cas9 ribonucleoproteins works?

 

Learn more about how delivery of CRISPR plasmids compares with delivery of ribonucleoproteins (RNPs) from our most recent white paper, Efficient CRISPR/Cas9 Delivery Using Nucleofector™ Technology: Comparison of Plasmid- and RNP-based Editing.

 

The authors developed a Nucleofection-based protocol for comparing NHEJ and HDR frequencies resulting from CRISPR/Cas9 delivered as plasmid or RNPs in K562 and Neuro2A cells.


Register to download the white paper from our technical resource collection.

 

Find out more about Nucleofector™ Technology and genome editing.

 


Solving Today's Challenges in Immunotherapy 

Lonza can provide high quality primary cells, transfection technology and services to support your transition from research into therapy.


Learn more about other immunotherapy products and resources:

 Hematopoietic and Immune Cells  Transfection of Immune Cells  Immunotherapy Knowledge Center

 

 

 

 

 

Technical Resources


Collection of white papers thumbnail 

 

Register to download PDFs >

White Papers and Technical Guides

 

Register and download these White Papers and Technical Guides on immunotherapy:

 

  • CRISPR/Cas9: using Nucleofection for efficient delivery of ribonucleoprotein (RNP) for targeted gene editing
  • Th17 Differentiation of peripheral blood CD4+ T cells into functional Th17 cells using a bead-based activation technology.
  • Genome Editing using Nucleofector™ Technology

 


Nature NK Cells Poster thumbnail 


Download PDF >


Request Printed Copy >

Free poster: Therapeutic approaches to enhance natural killer cell cytotoxicity 
published by Nature Reviews Drug Discovery


Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches – they have the potential to induce powerful antigen-independent immune responses against malignancies. Lonza has sponsored a poster, published by Nature Reviews Drug Discovery, which discusses NK cells in immunotherapy.


Download the free poster as a high-resolution PDF, and request your own printed copy to display in your lab.

 


Nature Immunotherapy Webinar thumbnail 

 

View Recording >

Webinar: Cancer Immunotherapy 
presented by Nature


Immunotherapy has the potential to achieve long-lasting regression and prevent relapse in cancer patients. View a recording of the Nature webinar, sponsored by Lonza to hear panel experts describe some of the most promising approaches to cancer immunotherapy, and the challenges that remain in translating scientific advances to clinical use.